Drew Badger

Drew Badger has extensive work experience in the field of Regulatory Affairs & Toxicology. Drew has held various roles at multiple companies since 1998. In 1998, they were a Toxicologist at Procter & Gamble. From 2001 to 2008, they were a Scientist/Senior Scientist and Director of Discovery Tox and Scientific Operations at Allergan Pharmaceuticals. From 2008 to 2011, they were a Senior Director of Toxicology & Regulatory Affairs at Amira Pharmaceuticals. From 2011 to 2018, they were a Director of Global Regulatory Leader & US Team Supervisor at Amgen. From 2018 to 2020, they were a Vice President/Head of Regulatory Affairs & Toxicology and Vice President/Head of Regulatory Affairs at Dermira, Inc., a wholly owned subsidiary of Eli Lilly & Company. From 2020 to 2022, they were a Vice President/Head of Regulatory Affairs & Toxicology at Capsida Biotherapeutics and President at DAB Consulting (www.dabconsultingservice.com). Currently, they are a Senior Vice-President of Regulatory Affairs & Toxicology at Apogee Therapeutics.

Drew Badger's education history includes a PhD in Pharmacology & Toxicology from the University of Arizona, which they obtained between 1993 and 1998. Prior to that, they earned a BS in Environmental Biology & Chemistry from Humboldt State University between 1988 and 1993. Drew also holds certifications from the Academy of Toxicological Sciences, the American Board of Toxicology, Inc., and the American Board of Toxicology, Inc., including a Fellow of the Academy of Toxicological Sciences obtained in July 2021, a Diplomate of the American Board of Toxicology obtained in 2002, and two DABT certifications obtained in 2002 and 2023.